Cocaine esterase (CocE) is a product of the bacterium Rhodococcus sp. which grows in the rhizosphere of coca plants in South America. The bacterium uses cocaine as its sole source of carbon and nitrogen, synthesizing CocE to initiate metabolism of the cocaine CocE is the most efficient enzyme (7.2 X 108) for metabolizing cocaine yet identified. It can both prevent and reverse extreme cocaine toxicity in our rodent models, and it has the potential to be developed into the first useful antagonist of cocaine's toxic effects. This proposal contains studies to continue to evaluate this enzyme in mouse and rat models of cocaine toxicity, to compare its effects with other protein-based anti-cocaine enzymes, and to use a variety of in vitro techniques, including pegylation and insertion into red blood cells, to improve this or other enzymes by reducing their antigenicity, and heat liability. These procedures are designed to prolong the enzyme's duration of action with the hopeful outcome that some insight will be obtained into how to make this substance useful in the long-term treatment of cocaine abuse. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA021416-01
Application #
7079791
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Hillery, Paul
Project Start
2006-05-10
Project End
2010-04-30
Budget Start
2006-05-10
Budget End
2007-04-30
Support Year
1
Fiscal Year
2006
Total Cost
$704,821
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Zheng, Fang; Zhan, Chang-Guo (2012) Modeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuse. PLoS Comput Biol 8:e1002610
Narasimhan, Diwahar; Woods, James H; Sunahara, Roger K (2012) Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction. Future Med Chem 4:137-50
Collins, Gregory T; Narasimhan, Diwahar; Cunningham, Alyssa R et al. (2012) Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats. Neuropsychopharmacology 37:1092-103
Huang, Xiaoqin; Zhao, Xinyun; Zheng, Fang et al. (2012) Cocaine esterase-cocaine binding process and the free energy profiles by molecular dynamics and potential of mean force simulations. J Phys Chem B 116:3361-8
Bargagna-Mohan, Paola; Paranthan, Riya R; Hamza, Adel et al. (2012) Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin. J Biol Chem 287:989-1006
Brim, Remy L; Noon, Kathleen R; Collins, Gregory T et al. (2012) The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination. J Pharmacol Exp Ther 340:83-95
Zheng, Fang; Zhan, Chang-Guo (2012) Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose? Future Med Chem 4:125-8
Brim, Remy L; Noon, Kathleen R; Collins, Gregory T et al. (2011) The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry. Mol Pharmacol 80:1119-27
Brim, Remy L; Noon, Kathleen R; Nichols, Joseph et al. (2011) Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs. Drug Alcohol Depend 119:224-8
Huang, Xiaoqin; Zheng, Fang; Zhan, Chang-Guo (2011) Human butyrylcholinesterase-cocaine binding pathway and free energy profiles by molecular dynamics and potential of mean force simulations. J Phys Chem B 115:11254-60

Showing the most recent 10 out of 34 publications